The present work is concerned with designing new phenazinamine derivatives using computer aided drug design and to perform insilico screening of designed phenazinamine derivatives. These compounds were designed on the basis of literature information, essential for anticancer activity through PASS, toxicity risk assessment, GQSAR and molecular docking studies. Compounds which were optimized and shortlisted by molecular modeling studies viz., new phenazinamine derivatives; were synthesized, structurally elucidated by spectroscopic studies and screened for invitro anticancer activity. It was found that these derivatives in suitable concentrations exhibited anticancer activity comparable to standard Imatinib. In molecular docking studies, the interaction of 2-phenazinamine derivatives with Bcr-Abl tyrosine kinase enzyme was studied. The most active compounds of dataset were found to possess good dock scores and binding affinity towards this enzyme. It was observed that insilico and invitro anticancer activity results of these 2-phenazinamine derivatives correlate well with results obtained from docking.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The present work is concerned with designing new phenazinamine derivatives using computer aided drug design and to perform insilico screening of designed phenazinamine derivatives. These compounds were designed on the basis of literature information, essential for anticancer activity through PASS, toxicity risk assessment, GQSAR and molecular docking studies. Compounds which were optimized and shortlisted by molecular modeling studies viz., new phenazinamine derivatives; were synthesized, structurally elucidated by spectroscopic studies and screened for invitro anticancer activity. It was found that these derivatives in suitable concentrations exhibited anticancer activity comparable to standard Imatinib. In molecular docking studies, the interaction of 2-phenazinamine derivatives with Bcr-Abl tyrosine kinase enzyme was studied. The most active compounds of dataset were found to possess good dock scores and binding affinity towards this enzyme. It was observed that insilico and invitro anticancer activity results of these 2-phenazinamine derivatives correlate well with results obtained from docking. 324 pp. Englisch. N° de réf. du vendeur 9786202803366
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. N° de réf. du vendeur 493983179
Quantité disponible : Plus de 20 disponibles
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The present work is concerned with designing new phenazinamine derivatives using computer aided drug design and to perform insilico screening of designed phenazinamine derivatives. These compounds were designed on the basis of literature information, essential for anticancer activity through PASS, toxicity risk assessment, GQSAR and molecular docking studies. Compounds which were optimized and shortlisted by molecular modeling studies viz., new phenazinamine derivatives; were synthesized, structurally elucidated by spectroscopic studies and screened for invitro anticancer activity. It was found that these derivatives in suitable concentrations exhibited anticancer activity comparable to standard Imatinib. In molecular docking studies, the interaction of 2-phenazinamine derivatives with Bcr-Abl tyrosine kinase enzyme was studied. The most active compounds of dataset were found to possess good dock scores and binding affinity towards this enzyme. It was observed that insilico and invitro anticancer activity results of these 2-phenazinamine derivatives correlate well with results obtained from docking. N° de réf. du vendeur 9786202803366
Quantité disponible : 1 disponible(s)
Vendeur : Books Puddle, Woodside, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26386419525
Quantité disponible : 4 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The present work is concerned with designing new phenazinamine derivatives using computer aided drug design and to perform insilico screening of designed phenazinamine derivatives. These compounds were designed on the basis of literature information, essential for anticancer activity through PASS, toxicity risk assessment, GQSAR and molecular docking studies. Compounds which were optimized and shortlisted by molecular modeling studies viz., new phenazinamine derivatives; were synthesized, structurally elucidated by spectroscopic studies and screened for invitro anticancer activity. It was found that these derivatives in suitable concentrations exhibited anticancer activity comparable to standard Imatinib. In molecular docking studies, the interaction of 2-phenazinamine derivatives with Bcr-Abl tyrosine kinase enzyme was studied. The most active compounds of dataset were found to possess good dock scores and binding affinity towards this enzyme. It was observed that insilico and invitro anticancer activity results of these 2-phenazinamine derivatives correlate well with results obtained from docking.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 324 pp. Englisch. N° de réf. du vendeur 9786202803366
Quantité disponible : 1 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 394261658
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND. N° de réf. du vendeur 18386419535
Quantité disponible : 4 disponible(s)